钠-葡萄糖协同转运蛋白2抑制剂联合胰岛素治疗1型糖尿病疗效与

钠-葡萄糖协同转运蛋白2抑制剂联合胰岛素治疗1型糖尿病疗效与安全性的Meta分析(5)

http://www.100md.com 2021年1月1日《中国药房》 202101

[ 9 ] PARESH D，CHANTAL M，MOSHE P，et al. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes：the depict-1 52-week study[J]. Diabetes Care，2018，41(12)：2552-2559.

[10] CHANTAL M，PARESH D，PIETER G，et al. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the depict-2 study)：24-week results from a randomized controlled trial[J]. Diabetes Care ......

上一页第 1 2 3 4 5 页

百拇医药网 http://www.100md.com/html/paper/1001-0408/2021/01/17-4.htm

您现在查看是摘要页，全文长 3539 字符。